Fingerprint
Dive into the research topics of 'A phase 1b clinical trial of the CD40-activating antibody CP-870,893 in combination with cisplatin and pemetrexed in malignant pleural mesothelioma'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically